RANKL promotes the expansion of mammary epithelial cells in osteoporotic TgRANKL mouse models

RANKL promotes the expansion of mammary epithelial cells in osteoporotic TgRANKL mouse models

Bibliographic Details
Main Authors:	Anthi Kolokotroni, Vagelis Rinotas, Evi Gkikopoulou, Eirini Efstathiou, Eleni Dermitzaki, Thanasis Rentis, Danae Zareifi, Ilias Lymperopoulos, Martina Samiotaki, Leonidas Alexopoulos, George Panayotou, Eleni Douni
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352187220304435

Similar Items

Establishment of progesterone-induced mammary carcinogenesis in a humanized TgRANKL osteoporotic mouse model
by: Anthi Kolokotroni, et al.
Published: (2020-10-01)

Bone remodeling mechanisms in osteoporotic TgRANKL transgenic mouse models
by: Vagelis Rinotas, et al.
Published: (2020-10-01)

Investigating Denosumab discontinuation in the TgRANKL osteoporotic mouse model
by: Vagelis Rinotas, et al.
Published: (2021-04-01)

Transcriptomic analysis in the TgRANKL mouse model of osteoporosis reveals miRNAs as potent regulators of bone remodeling
by: Elisavet Ioannidou, et al.
Published: (2021-04-01)

Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics
by: Anthi Kolokotroni, et al.
Published: (2023-08-01)

Studying the role of RANKL in breast cancer and bone metastasis mouse models
by: Evi Gkikopoulou, et al.
Published: (2021-04-01)

New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis
by: Maria Papadaki, et al.
Published: (2019-02-01)

In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
by: Georgia Melagraki, et al.
Published: (2018-07-01)

Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors
by: Vagelis Rinotas, et al.
Published: (2023-07-01)

Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).
by: Georgia Melagraki, et al.
Published: (2017-04-01)

RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
by: Nicolas Bonnet, et al.
Published: (2023-02-01)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
by: Yuria Jang, et al.
Published: (2021-01-01)

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
by: Lau, Y, et al.
Published: (2007)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
by: Aristofania Simatou, et al.
Published: (2020-10-01)

RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway
by: Mineon Park, et al.
Published: (2021-06-01)

When all rankings do is rankle
by: Abd Razak, Dzulkifli
Published: (2009)

RANKL-independent osteoclastogenesis in Paget's disease
by: Jones, F, et al.
Published: (2008)

The Roadmap of RANKL/RANK Pathway in Cancer
by: Sandra Casimiro, et al.
Published: (2021-08-01)

RANKL regulates male reproductive function
by: Martin Blomberg Jensen, et al.
Published: (2021-04-01)

Biology of the RANKL-RANK-OPG System
by: Yongwon eChoi, et al.
Published: (2014-10-01)

Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis
by: Dane Huang, et al.
Published: (2022-09-01)

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT
by: Hemingway, F, et al.
Published: (2013)

Osteoclast differentiation in Paget's disease is hypersensitive to RANKL.
by: Neale, S, et al.
Published: (2000)

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT.
by: Hemingway, F, et al.
Published: (2013)

Immuno-PET Molecular Imaging of RANKL in Cancer
by: Jonatan Dewulf, et al.
Published: (2021-04-01)

Effects of RANKL-targeted therapy in immunity and cancer
by: Michael L Cheng, et al.
Published: (2014-01-01)

RANK, RANKL and osteoprotegerin in arthritic bone loss
by: M.C. Bezerra, et al.
Published: (2005-02-01)

RANK/RANKL/OPG system in the intervertebral disc
by: Norihiko Takegami, et al.
Published: (2017-06-01)

Salivary level of RANKL and OPG in chronic periodontitis
by: Batool H Al-Ghurabi, et al.
Published: (2015-03-01)

Analyses of RANK and RANKL in the post-GWAS context: functional evidence of vitamin D stimulation through a RANKL distal region.
by: Yoskovitz, G, et al.
Published: (2013)

Identification of novel mutation in RANKL by whole‐exome sequencing in a Thai family with osteopetrosis; a case report and review of RANKL osteopetrosis
by: Pongtawat Lertwilaiwittaya, et al.
Published: (2021-07-01)

Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis
by: Michalis Spartalis, et al.
Published: (2023-02-01)

Ewing sarcoma cells express RANKL and support osteoclastogenesis.
by: Taylor, R, et al.
Published: (2011)

Ewing sarcoma cells express RANKL and support osteoclastogenesis
by: Taylor, R, et al.
Published: (2011)

Structural and functional insights of RANKL-RANK interaction and signaling.
by: Liu, C, et al.
Published: (2010)

The Role of RANKL and Involvement of Cementum in Orthodontic Root Resorption
by: Masaru Yamaguchi, et al.
Published: (2021-08-01)

Plumbagin modulates RANKL-induced osteoclast and osteoblast differentiation
by: Soni Ghumnani, et al.
Published: (2023-05-01)

The Effect of RANKL/OPG Balance on Reducing Implant Complications
by: Elizabeth R. Kapasa, et al.
Published: (2017-09-01)

Evaluation of Serum RANKL Level in Acute Coronary Syndrome
by: Ali A. Naji, et al.
Published: (2014-06-01)

Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis.
by: Ana Lleo, et al.
Published: (2016-01-01)